This inventor holds 20 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent and 1 EPO patent, primarily in Antifungal Proteins. Top assignees: Monsanto Company, Donald Danforth Plant Science Center, Monsanto Technology LLC. Active years: 1990-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Creve Coeur, MO (US) (1990 - 1994)
- Chesterfield, MO (US) (1996 - 2012)
- St. Louis, MO (US) (2013 - 2019)
Company Filing History:
11 out of 3,289 
6 out of 22 
2 out of 7,313 
Years Active: 1990-2025
Areas of Expertise:
Title: Innovations and Contributions of Dilip Maganlal Shah
Introduction
Dilip Maganlal Shah is a prominent inventor based in Chesterfield, MO (US), known for his significant contributions to the field of biotechnology. With a total of 19 patents to his name, he has made remarkable advancements in antimicrobial and antifungal technologies.
Latest Patents
Shah's latest patents include innovations in modified antimicrobial peptides. These patents disclose antimicrobial defensin peptide variants that comprise modified C-terminal fragments of a defensin, along with nucleic acids encoding the same. The compositions developed from these defensin variant peptides are aimed at controlling microbial infections in both plants and vertebrate subjects, as well as addressing contamination in feedstuffs and foodstuffs. Additionally, he has developed antifungal plant proteins and peptides, particularly focusing on transgenic plants that express MtDef5 antifungal proteins. These plants exhibit high levels of resistance to susceptible fungi, utilizing a recombinant DNA construct linked to a nucleic acid sequence encoding these molecules. His work also encompasses methods for producing such plants and protecting them against fungal infections, along with pharmaceutical compositions containing these innovative molecules.
Career Highlights
Throughout his career, Dilip Maganlal Shah has worked with notable organizations, including Monsanto Company and the Donald Danforth Plant Science Center. His work in these institutions has allowed him to push the boundaries of agricultural biotechnology and contribute to advancements in plant health and disease resistance.
Collaborations
Shah has collaborated with esteemed colleagues, including Jihong Liang and Yonnie S Wu, to further enhance his research and development efforts in the field of biotechnology.
Conclusion
Dilip Maganlal Shah's innovative work in antimicrobial and antifungal technologies has made a significant impact on agricultural biotechnology. His contributions continue to pave the way for advancements in plant health and disease management.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile